Hormone replacement therapy and cognitive performance in postmenopausal women - a review by cognitive domain

被引:23
|
作者
Low, LF [1 ]
Anstey, KJ [1 ]
机构
[1] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT 0200, Australia
来源
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS | 2006年 / 30卷 / 01期
关键词
HRT; estrogen; cognition; dementia; memory;
D O I
10.1016/j.neubiorev.2005.05.003
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Laboratory, animal and neuroimaging evidences suggest that hormone replacement therapy (HRT) may be beneficial to human cognition. This systematic review includes 26 studies on the association between HRT and cognition and 17 studies on HRT and risk of dementia. It was hypothesised that HRT would have a positive association with cognitive speed and verbal memory and possibly visual memory but not with executive functioning, and would be associated with a decreased risk of dementia. Evidence for HRT's neuroenhancing and neuroprotective properties was also evaluated. There was significant statistical and clinical heterogeneity among studies precluding meta-analysis. Results showed no consistent relationship between HRT and performance in any cognitive domain. Cross-sectional studies tended to report more positive results than longitudinal studies and randomised-controlled trials, particularly in the areas of verbal memory and executive functioning. HRT was associated with decreased risk of dementia in observational studies, but with increased risk in one randomised-controlled trial. Cognitive improvement or maintenance are not secondary benefits of HRT. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:66 / 84
页数:19
相关论文
共 50 条
  • [41] Estradiol and NorgestimateA Review of Their Combined Use as Hormone Replacement Therapy in Postmenopausal Women
    Monique P. Curran
    Antona J. Wagstaff
    Drugs & Aging, 2001, 18 : 863 - 885
  • [42] Estradiol and dydrogesterone - A review of their combined use as hormone replacement therapy in postmenopausal women
    Foster, RH
    Balfour, JA
    DRUGS & AGING, 1997, 11 (04) : 309 - 332
  • [43] Estradiol and norgestimate - A review of their combined use as hormone replacement therapy in postmenopausal women
    Curran, MP
    Wagstaff, AJ
    DRUGS & AGING, 2001, 18 (11) : 863 - 885
  • [44] Hormone levels and cognitive function in postmenopausal midlife women
    Ryan, Joanne
    Stanczyk, Frank Z.
    Dennerstein, Lorraine
    Mack, Wendy J.
    Clark, Margaret S.
    Szoeke, Cassandra
    Kildea, Daniel
    Hendersong, Victor W.
    NEUROBIOLOGY OF AGING, 2012, 33 (07) : 1138 - +
  • [45] Hormone levels and cognitive function in postmenopausal midlife women
    Ryan, Joanne
    Stanczyk, Frank Z.
    Dennerstein, Lorraine
    Mack, Wendy J.
    Clark, Margaret S.
    Szoeke, Cassandra
    Kildea, Daniel
    Henderson, Victor W.
    NEUROBIOLOGY OF AGING, 2012, 33 (03)
  • [46] Hormone replacement therapy and urinary prostaglandins in postmenopausal women
    Akgül, C
    Canbaz, M
    Vural, P
    Yildirim, A
    Geren, N
    MATURITAS, 1998, 30 (01) : 79 - 83
  • [47] Homocysteine in postmenopausal women and the importance of hormone replacement therapy
    Mijatovic, V
    van der Mooren, MJ
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (08) : 764 - 767
  • [48] Mammographic density in women on postmenopausal hormone replacement therapy
    Leung, W
    Goldberg, F
    Zee, B
    Sterns, E
    SURGERY, 1997, 122 (04) : 669 - 673
  • [49] Hormone replacement therapy and quality of life in postmenopausal women
    Tak, Young Jin
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (12): : 1355 - 1356
  • [50] Is hormone replacement therapy prescribed for postmenopausal diabetic women?
    Feher, MD
    Isaacs, AJ
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1996, 50 (08): : 431 - 432